Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial. (Q48339039)

10 February 2018

title

Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial. (English)

1 reference

10 February 2018

0 references

0 references

1 reference

4

Richard G Ellenbogen

1 reference

10 February 2018

author name string

Nancy R Temkin

1

1 reference

10 February 2018

Gail D Anderson

2

1 reference

10 February 2018

H Richard Winn

3

1 reference

10 February 2018

Gavin W Britz

5

1 reference

10 February 2018

James Schuster

6

1 reference

10 February 2018

Timothy Lucas

7

1 reference

10 February 2018

David W Newell

8

1 reference

10 February 2018

Pamela Nelson Mansfield

9

1 reference

10 February 2018

Joan E Machamer

10

1 reference

10 February 2018

Jason Barber

11

1 reference

10 February 2018

Sureyya S Dikmen

12

1 reference

10 February 2018

publication date

1 January 2007

1 reference

10 February 2018

published in

Lancet Neurology

1 reference

10 February 2018

volume

6

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

page(s)

29-38

1 reference

10 February 2018

Traumatic Brain Injury in the United States: A Public Health Perspective

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970630-5

7 January 2021

Novel pharmacologic therapies in the treatment of experimental traumatic brain injury: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970630-5

7 January 2021

Predictive value of serum ionized but not total magnesium levels in head injuries

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970630-5

7 January 2021

Clinical trials in head injury

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970630-5

7 January 2021

Magnesium deficiency exacerbates and pretreatment improves outcome following traumatic brain injury in rats: 31P magnetic resonance spectroscopy and behavioral studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970630-5

7 January 2021

Postinjury treatment with magnesium chloride attenuates cortical damage after traumatic brain injury in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970630-5

7 January 2021

Acute cytoskeletal alterations and cell death induced by experimental brain injury are attenuated by magnesium treatment and exacerbated by magnesium deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970630-5

7 January 2021

Improved motor outcome in response to magnesium therapy received up to 24 hours after traumatic diffuse axonal brain injury in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970630-5

7 January 2021

Magnesium sulphate subcutaneously injected protects against kainate-induced convulsions and neurodegeneration: In vivo study on the rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970630-5

7 January 2021

Peripheral magnesium sulfate enters the brain and increases the threshold for hippocampal seizures in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970630-5

7 January 2021

Assessment of coma and impaired consciousness. A practical scale

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970630-5

7 January 2021

Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970630-5

7 January 2021

A randomized, double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970630-5

7 January 2021

Procedures for comparing samples with multiple endpoints

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970630-5

7 January 2021

A Multiple Testing Procedure for Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970630-5

7 January 2021

Functional status examination: a new instrument for assessing outcome in traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970630-5

7 January 2021

Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970630-5

7 January 2021

Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970630-5

7 January 2021

Dynamic changes in N-methyl-D-aspartate receptors after closed head injury in mice: Implications for treatment of neurological and cognitive deficits

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970630-5

7 January 2021

Acute treatment with MgSO4 attenuates long-term hippocampal tissue loss after brain trauma in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970630-5

7 January 2021

Analysis of the brain bioavailability of peripherally administered magnesium sulfate: A study in humans with acute brain injury undergoing prolonged induced hypermagnesemia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970630-5

7 January 2021

Regional patterns of blood-brain barrier breakdown following central and lateral fluid percussion injury in rodents.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970630-5

7 January 2021

Neuroprotective effects of MgSO4 and MgCl2 in closed head injury: a comparative phosphorus NMR study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970630-5

7 January 2021

10.1016/S1474-4422(06)70630-5

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

17166799

1 reference

10 February 2018